Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro

This publication has 31 references indexed in Scilit:

• Histone deacetylase inhibitor Helminthosporium carbonum (HC)‐toxin suppresses the malignant phenotype of neuroblastoma cells
  International Journal of Cancer, 2007
• High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status
  Clinical Cancer Research, 2007
• Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease
  Cancer Letters, 2006
• Survivin mRNA Levels Are Associated With Biology of Disease and Patient Survival in Neuroblastoma: A Report From the Children's Oncology Group
  Journal of Pediatric Hematology/Oncology, 2006
• Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
  Journal of Clinical Oncology, 2005
• Significance of Survivin mRNA Expression in Prognosis of Neuroblastoma
  Biological & Pharmaceutical Bulletin, 2005
• Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
  Nature, 2004
• Neuroblastoma: biology and molecular and chromosomal pathology
  Published by Elsevier ,2003
• Retinoid therapy of high-risk neuroblastoma
  Cancer Letters, 2003
• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
  New England Journal of Medicine, 1999